Morning movers: 3M jumps 6% as guidance rises

Recovery note: this is the July 21, 2026 pre-market snapshot, published after the session because the 7:00 a.m. ET deadline was missed. The prices below are delayed Yahoo Finance prints from 9:14 a.m. ET; the live ticker strip now shows newer values. No July 21 overnight read was live at the quote cut, so this brief stays company-specific.

The tape at 9:14 a.m. ET

3M: guidance rises with industrial demand

3M reported $6.5 billion of Q2 sales, up 2.4% year over year. Adjusted organic sales grew 5.4%, while adjusted earnings reached $2.40 a share, up 11%. The company lifted 2026 adjusted-EPS guidance to $8.80–$8.95 from $8.50–$8.70.

What the market watched: the 9:00 a.m. ET call, follow-through above the $159.11 prior close, and whether the move approached $177.41. In plain terms: the quarter improved the profit map, but the opening gap still needed regular-session confirmation.

General Motors: the adjusted outlook moves higher

GM posted $48.0 billion of Q2 revenue, $1.3 billion of net income attributable to stockholders and $3.9 billion of EBIT-adjusted. It raised 2026 EBIT-adjusted guidance to $14–$16 billion from $13.5–$15.5 billion and adjusted-EPS guidance to $12–$14 from $11.50–$13.50.

What the market watched: the 8:30 a.m. ET call, North American margins, warranty costs and consumer pricing. In plain terms: better adjusted cash and profit expectations supported the shares, but the GAAP-versus-adjusted bridge still deserved attention.

Danaher: a raised EPS range cannot hide the revenue reset

Danaher reported $6.3 billion of revenue, up 5.5%, and adjusted diluted earnings of $1.94 a share, up 8%. Core revenue grew 3.0%. The company raised full-year adjusted EPS guidance to $8.45–$8.60, yet kept core-growth guidance at only 3%–4% after cutting the previous upper end.

What the market watched: the 8:00 a.m. ET call, biotechnology shipment timing, respiratory-testing pressure and the $160.93 reference. In plain terms: stronger orders did not erase the near-term revenue disappointment.

MSCI: good growth, a more expensive plan

MSCI's Q2 operating revenue rose 12.2% to $867.0 million, and adjusted EPS climbed 18.5% to $4.94. Total operating expenses were $379.5 million, up 9.2%. The company raised its 2026 operating-expense forecast to $1.535–$1.575 billion from $1.490–$1.530 billion.

What the market watched: whether index-fee growth and a 95.3% retention rate could outweigh the higher cost plan. In plain terms: the quarter was profitable, but investors marked down the price they would pay for that growth.

Also on the radar

• NVS, SCHW and NOC: Nasdaq scheduled all three to report before the July 21 open, but this recovered run did not freeze a complete official-release plus cross-checked pre-market quote bundle for them, so none was promoted to a feature.
• Yahoo's trending, gainers, losers and most-active screeners returned HTTP 429 on the initial call and one retry. The successful Nasdaq mover feed and Google News sweep supplied candidate discovery instead.
• StockTwits and Reddit returned HTTP 403. Google Trends was checked as a signal only; no social claim became a catalyst or entered the article.

What to watch on Tuesday, July 21, 2026

• 8:00 a.m. ET: Danaher's call—bioprocessing shipments and the 3%–4% core-growth range.
• 8:30 a.m. ET: GM's call—pricing, warranty costs, North American margins and EV losses.
• 9:00 a.m. ET: 3M's call—guidance, industrial demand and input-cost pressure.
• 9:30 a.m. ET: the opening auction and the first executable option quotes; MSCI's higher cost plan was the key non-industrial earnings debate.